Chinese english Germany Japanese Korea

3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one

3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one Struktur
374908-54-0
CAS-Nr.
374908-54-0
Englisch Name:
3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
Synonyma:
3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one;4H-Cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one, 2-[(1,3-benzodioxol-5-ylmethyl)thio]-3,5,6,7-tetrahydro-3-(2-propen-1-yl)-
CBNumber:
CB01954418
Summenformel:
C20H18N2O3S2
Molgewicht:
398.5
MOL-Datei:
374908-54-0.mol
Request For Quotation

3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one Eigenschaften

Sicherheit

3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one Chemische Eigenschaften,Einsatz,Produktion Methoden

3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Specs --
 info@specs.net The Netherlands 6835 70
  • 3-allyl-2-[(1,3-benzodioxol-5-ylmethyl)sulfanyl]-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
  • 4H-Cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one, 2-[(1,3-benzodioxol-5-ylmethyl)thio]-3,5,6,7-tetrahydro-3-(2-propen-1-yl)-
  • 374908-54-0
  • C20H18N2O3S2
Copyright 2019 © ChemicalBook. All rights reserved